TABLE 3.
Antimicrobial resistance phenotypes of 2,763 MDR E. coli urinary tract isolates as reported to TSN 1 January to 30 September 2000
| Antimicrobial resistance phenotype | No. of isolates | % MDR isolates | % Total isolatesa |
|---|---|---|---|
| Ampicillin, cephalothin, SXT | 1,600 | 57.9 | 4.1 |
| Ampicillin, cephalothin, ciprofloxacin, SXT | 487 | 17.6 | 1.3 |
| Ampicillin, ciprofloxacin, SXT | 316 | 11.4 | 0.8 |
| Ampicillin, cephalothin, ciprofloxacin | 103 | 3.7 | 0.3 |
| Ampicillin, cephalothin, ciprofloxacin, nitrofurantoin, SXT | 62 | 2.2 | 0.2 |
| Cephalothin, ciprofloxacin, SXT | 45 | 1.6 | 0.1 |
| Ampicillin, cephalothin, nitrofurantoin | 38 | 1.4 | 0.1 |
| Ampicillin, cephalothin, nitrofurantoin, SXT | 30 | 1.1 | 0.1 |
| Ampicillin, nitrofurantoin, SXT | 23 | 0.8 | 0.1 |
| Ampicillin, ciprofloxacin, nitrofurantoin, SXT | 16 | 0.6 | <0.1 |
| Ampicillin, cephalothin, ciprofloxacin, nitrofurantoin | 16 | 0.6 | <0.1 |
| Ampicillin, ciprofloxacin, nitrofurantoin | 10 | 0.4 | <0.1 |
| Cephalothin, ciprofloxacin, nitrofurantoin, SXT | 6 | 0.2 | <0.1 |
| Cephalothin, ciprofloxacin, nitrofurantoin | 5 | 0.2 | <0.1 |
| Ciprofloxacin, nitrofurantoin, SXT | 5 | 0.5 | <0.1 |
| Cephalothin, nitrofurantoin, SXT | 1 | <0.1 | <0.1 |
a
The total number of isolates was 38,835.